Non-viral infections in children after renal transplantation

Pediatric Nephrology

Volumn 27, Issue 9, 2012, Pages 1465-1476

  Mencarelli, Francesca ^a   Marks, Stephen D ^a  

^a Hospital for Children   (United Kingdom)

Author keywords

Graft survival; Immunosuppression minimisation; Non viral infection; Paediatric renal transplantation; Risk of infection

Indexed keywords

AZATHIOPRINE; BASILIXIMAB; CIPROFLOXACIN; COTRIMOXAZOLE; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; POLYCLONAL ANTIBODY; RAPAMYCIN;

BACTEREMIA; BACTERIAL INFECTION; CATHETER INFECTION; CHILDHOOD DISEASE; CYTOMEGALOVIRUS INFECTION; GRAFT RECIPIENT; GRAFT SURVIVAL; HEMODIALYSIS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY ALLOGRAFT; KIDNEY ALLOGRAFT REJECTION; KIDNEY TRANSPLANTATION; LOWER URINARY TRACT SYMPTOM; MYCOSIS; PARASITOSIS; PERITONEAL DIALYSIS; POSTOPERATIVE COMPLICATION; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; REVIEW; RISK FACTOR; URINARY TRACT INFECTION;

BACTERIAL INFECTIONS; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOSUPPRESSION; INCIDENCE; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MYCOSES; PARASITIC DISEASES; TRANSPLANTATION, HOMOLOGOUS;

EID: 84864442101     PISSN: 0931041X     EISSN: 1432198X     Source Type: Journal    
DOI: 10.1007/s00467-011-2099-z     Document Type: Review

References (103)

1. Fine RN (1985) Renal transplantation for children-the only realistic choice. Kidney Int Suppl 17:15-17
2. Ingelfinger JR, Grupe WE, Harmon WE, Femback SK, Levey RH (1981) Growth acceleration following renal transplantation in children less than 7 years of age. Pediatrics 68:255-259 (Pubitemid 11046470)
3. Dharnidharka VR, Caillard S, Agodoa LY, Abbott KC (2006) Infection frequency and profile in different age groups of kidney transplant recipients. Transplantation 27:1662-1667 (Pubitemid 43948299)
4. NAPRTCS 2005 annual report, available at https://web.emmes. com/study/ped/resources/annlrept2005.pdf
5. Groothoff JW, Gruppen MP, Offringa M, Hutten J, Lilien MR, Van De Kar NJ, Wolff ED, Davin JC, Heymans HS (2002) Mortality and causes of death of endstage renal disease in children: a Dutch cohort study. Kidney Int 61:621-629 (Pubitemid 34102605)
6. Van Damme-Lombaerts R, Herman J, Coosemans W,Pirenne J (2001) Pediatric renal transplantation: a single Belgian center experience over 20 years. Pediatr Transplant 5:447-451 (Pubitemid 33095210)
7. Johnson RJ, Armstrong S, Belger MA, Fuggle SV, Martin S, Middleton D, Ray TC, Rigden SP, Verrier-Jones K, Morris PJ (2002) Paediatric Task Force of United Kingdom, Bristol, UK: the outcome of pediatric cadaveric renal transplantation in the UK and Eire. Pediatr Transplant 6:367-377 (Pubitemid 35265187)
8. Harzallah K, Floret D, Martin X, Cochat P (2004) Mortality in pediatric renal transplants: 15 years' experience. Arch Pediatr 11:916-920 (Pubitemid 39006247)
9. Rees L, Shroff R, Hutchinson C, Fernando ON, Trompeter RS (2007) Long-term outcome of paediatric renal transplantation: follow-up of 300 children from 1973 to 2000. Nephron Clin Pract 105:c68-c76 (Pubitemid 46143909)
10. Dharnidharka VR, Stablein DM, Harmon WE (2004) Posttransplant infections now exceed acute rejection as cause for hospitalization: a report of the NAPRTCS. Am J Transplant 4:384-389 (Pubitemid 38282294)
11. Harmon WE (1991) Opportunistic infections in children following renal transplantation. Pediatr Nephrol 5:118-125
12. Rubin RH (1993) Infectious disease complications of renal transplantation. Kidney Int 44:221-236 (Pubitemid 23198047)
13. Bilal J, Nicholls K, Becker GJ,Walker RG (1999) Impact of acute rejection therapy on infections and malignancies in renal transplant recipients. Transplantation 68:1597-1603
14. Fishman JA (2007) Infection in solid-organ transplant recipients. N Engl J Med 357:2601-2614 (Pubitemid 350294226)
15. Fishman JA, Rubin RH (1998) Infection in organ transplant recipients. N Engl J Med 24:1743-1752
16. Rubin RH, Wolfson JS, Cosimi AB, Tolkoff-Rubin NE (1981) Infections in renal transplant recipients. Am J Med 70:405-411
17. Fishman JA (2007) Infection in renal transplant recipients. Semin Nephrol 27:445-461 (Pubitemid 47009007)
18. Rubin RH, Cosimi AB, Tolkoff-Rubin NE, Russell PS, Hirsch MS (1977) Infectious disease syndromes attributable to cytomegalovirus and their significance among renal transplant recipients. Transplantation 24:458-464 (Pubitemid 9126427)
19. Rubin RH, Sester M, Gärtner BC (1989) The indirect effects of cytomegalovirus infection on the outcome of organ transplantation. JAMA 261:3607-3609
20. Fonseca-Aten M, Michaels MG (2006) Infections in pediatric solid organ transplant recipients. Semin Pediatr Surg 15:153-161 (Pubitemid 43963385)
21. Leigh JDA (1971) Bacteraemia in patients receiving human cadaveric renal transplants. Pathol Clin 24:295-299
22. Tolkoff-Rubin NE, Rubin RH (1992) Opportunistic fungal and bacterial infection in the renal transplant recipient. J Am Soc Nephrol 2:S264-S269
23. DeVault GA Jr., King JW, Rohr MS, Landreneau MD, Brown ST, McDonald JC (1990) Opportunistic infections with Strongyloides stercoralis in renal transplantation. Rev Infect Dis 12:653-671 (Pubitemid 20223416)
24. Fernandez-Guerrero ML, Aguado JM, Buzon L, Barros C, Montalbán C, Martín T, Bouza E (1987) Visceral leishmaniasis in immunocompromised hosts. Am J Med 83:1098-1102 (Pubitemid 18098884)
25. Gourishankar S, Doucette K, Fenton J, Purych D, Kowlewska-Grochowska K, Preiksaitis J (2008) The use of donor and recipient screening for toxoplasma in the era of universal trimethoprim sulphametoxazole prophylaxis. J Transplant 85:980-985 (Pubitemid 351543161)
26. Anderson CB, Haid SD, Hruska KA, Etheredge EA (1978) Significance of microbial contamination of stored cadaver kidneys. Arch Surg 113:269-271 (Pubitemid 8308265)
27. Benoit G, Tiguert R, Bensadoun H, Hammoudi Y, Hiesse C, Jacques L, Fries D, Jardin A (1988) Incidence of transport medium contamination in cadaver kidney procurement. Transplant Proc 20:895 (Pubitemid 18261338)
28. Mora M, Wilms H, Kirste G (1991) Significance of bacterial contamination of cadaver donor renal allografts before transplantation. Transplant Proc 23:2648
29. Bijnen AB, Weimar W, Dik P, Oberop H, Jeekel J (1984) The hazard of transplanting contaminated kidneys. Transplant Proc: 16:27
30. McCoy GC, Loening S, Braun WE, Magnusson MO, Banowsky LH, McHenry MC (1975) The fate of cadaver renal allografts contaminated before transplantation. Transplantation 20:467
31. Wilson CH, Gregory RT, Wheeler JR, Hurwitz RL, Vansant JH, Thomas FT (1979) Complications of end-to-side renal artery anastomosis in renal transplant infection. Vasc Surg 13:207
32. Doig RL, Boyd PJR, Eykyn S (1975) Staphylococcus aureus transmitted in transplanted kidneys. Lancet 9:243
33. Wakelin SJ, Casey J, Robertson A, Friend P, Bryon C, Hester Yorke J, Rigden SP, Xavier EFS, Pareja-Cebrian L, Forsythe JLR, Morris PJ (2005) The incidence and importance of bacterial contaminants of cadaveric renal perfusion fluid. Transpl Int 17:680-686 (Pubitemid 40558225)
34. Arbeiter K, Pichler A, Muerwald G, Mueller T, Bidmon B, Balzar E, Ruffingshofer D, Greenbaum L, Aufricht C (2001) Timing of peritoneal dialysis catheter removal after pediatric renal transplantation. Perit Dial Int 21:467-470 (Pubitemid 32998452)
35. Palmer JA, Kaiser BA, Polinsky MS, Dunn SP, Braas C, Waltz R, Baluarte HJ (1994) Peritoneal dialysis catheter infections in children after renal transplantation: choosing the time of removal. Pediatr Nephrol 8:715-718
36. Wilson CH, Bhatti AB, Rix DA, Manas DM (2005) Routine intraoperative ureteric stenting for kidney transplant recipients. Cochrane Database Syst Rev 19:4 CD004925
37. Patel P, Olsburgh J, Marks SD (2010) Timing of ureteric stent removal in pediatric renal transplant recipients (RTR). Pediatr Nephrol 25:1779-2004
38. Mueller T, Resinger C, Ruffingshofer D, Arbeiter K, Balzar E, Aufricht C (2003) Urinary tract infections beyond the early posttransplant period in pediatric renal graft recipients. Wien Klin Wochenschr 115:385-388 (Pubitemid 36827699)
39. Ranchin B, Chapuis F, Dawhara M, Canterino I, Hadj-Aissa A, Said MH, Parchoux B, Dubourg L, Pouillaude JM, Floret D, Martin X, Cochat P (2000) Vesicoureteral reflux after kidney transplantation in children. Nephrol Dial Transplant 15:1852-1858
40. Dunn SP, Vinocur CD, Hanevold C, Wagner CW, Weintraub WH (1987) Pyelonephritis following pediatric renal transplant: increased incidence with vesicoureteral reflux. J Pediatr Surg 22:1095-1099 (Pubitemid 18024948)
41. Neuhaus TJ, Schwobel M, Schlumpf R, Offner G, Leumann E, Willi U (1997) Pyelonephritis and vesicoureteral reflux after renal transplantation in young children. J Urol 157:1400-1403 (Pubitemid 27130833)
42. Audard V, Amor M, Desvaux D, Pastural M, Baron C, Philippe R, Pardon A, Dahmane D, Lang P, Grimbert P (2005) Acute graft pyelonephritis: a potential cause of acute rejection in renal transplant. Transplantation 80:1128-1130 (Pubitemid 41611939)
43. Chuang P, Parikh CR, Langone A (2005) Urinary tract infections after renal transplantation: a retrospective review at two US transplant centers. Clin Transplant 19:230-235 (Pubitemid 40424895)
44. Sharifian M, Rees L, Trompeter RS (1998) High incidence of bacteriuria following renal transplantation in children. Nephrol Dial Transplant 13:432-435 (Pubitemid 28062208)
45. Ergin F, Arslan H, Yapar G, Karakayali H, Haberal M (2003) Urinary tract infections in renal transplant recipients. Transplant Proc 35:2685-2686 (Pubitemid 37378119)
46. Cairns HS, Spencer S, Hilson AJ, Rudge CJ, Neild GH (1994) 99mTc-DMSA imaging with tomography in renal transplant recipients with abnormal lower urinary tracts. Nephrol Dial Transplant 9:1157-1161 (Pubitemid 24254085)
47. Coulthard MG, Keir MJ (2006) Reflux nephropathy in kidney transplants, demonstrated by dimercaptosuccinic acid scanning. Transplantation 82:205-210 (Pubitemid 44126817)
48. Hutchinson C, Beckett M, Kiratli P, Gordon I, Trompeter RS, Rees L (2003) The significance of a defect on DMSA scan in children with renal transplants. Pediatr Transplant 7:441-445 (Pubitemid 37466202)
49. Ali-El-Dein B, Abol-Enein H, El-Husseini A, Osman Y, Shehab El-Din AB, Ghoneim MA (2004) Renal transplantation in children with abnormal lower urinary tract. Transplant Proc 36:2968-2973 (Pubitemid 41126718)
50. Otukesh H, Sharifian M, Simfroosh N, Basiri A, Hoseini R, Sedigh N, Golnari P, Rezai M, Fereshtenejad M (2005) Outcome of renal transplantation in children with low urinary tract abnormality. Transplant Proc 37:3071-3074 (Pubitemid 41435621)
51. Mendizabal S, Estornell F, Zamora I, Sabater A, Ibarra FG, Simon J (2005) Renal transplantation in children with severe bladder dysfunction. J Urol 173:226-229 (Pubitemid 39627722)
52. Franc-Guimond J, Gonzalez R (2004) Renal transplantation in children with reconstructed bladders. Transplantation 77:1116-1120 (Pubitemid 38508936)
53. Neild GH, Dakmish A, Wood S, Nauth-Misir R, Woodhouse CR (2004) Renal transplantation in adults with abnormal bladders. Transplantation 77:1123-1127 (Pubitemid 38508938)
54. Ross JH, Kay R, Novick AC, Hayes JM, Hodge EE, Streem SB (1994) Long-term results of renal transplantation into the valve bladder. J Urol 151:1500-1504 (Pubitemid 24151286)
55. Riley P, Marks SD, Desai DY, Mushtaq I, Koffman G, Mamode N (2010) Dysfunction challenges facing renal transplantation in pediatric patients with lower urinary tract. Transplantation 89 (11):1299-1307
56. Casale P, Grady RW, Mitchell ME, Healey P (2005) Recurrent urinary tract infection in the post-transplant reflux nephropathy patient: is reflux in the native ureter the culprit? Pediatr Transplant 9:324-327 (Pubitemid 40780363)
57. Basiri A, Otookesh H, Simforoosh N, Hosseini R, Hosseini-Moghaddam SM, Sharifian M (2006) Does pre-transplantation antireflux surgery eliminate post-renal transplantation pyelonephritis in children? J Urol 175:1490-1492
58. Luke PP, Herz DB, Bellinger MF, Chakrabarti P, Vivas CA, Scantlebury VP, Hakala TR, Jevnikar AM, Jain A, Shapiro R, Jordan ML (2003) Long-term results of pediatric renal transplantation into a dysfunctional lower urinary tract. Transplantation 76:1578-1582 (Pubitemid 37549830)
59. Lopez Pereira P, Jaureguizar E, Martinez Urrutia MJ, Meseguer C, Navarro M (2000) Does treatment of bladder dysfunction prior to renal transplant improve outcome in patients with posterior urethral valves? Pediatr Transplant 4:118-122 (Pubitemid 30316822)
60. Ozcan O, Tekgul S, Duzova A, Aki F, Yuksel S, Bakkaloglu A, Erkan I, Bakkaloglu M (2006) How does the presence of urologic problems change the outcome of kidney transplantation in the pediatric age group. Transplant Proc 38:552-553
61. John U, Kemper JM (2009) Urinary tract infection after renal transplantation. Pediatr Nephrol 24:1129-1136
62. Flynn JT, Frisch K, Kershaw DB, Sedman AB, Bunchman TE (1999) Response to early measles-mumps-rubella vaccination in infants with chronic renal failure and/or receiving peritoneal dialysis. Adv Perit Dial 15:269-272
63. Kruger S, Mueller-Steinhardt M, Kirchner H, Kreft B (2001) A 5-year follow-up on antibody response after diphtheria and tetanus vaccination in hemodialysis patients. Am J Kidney Dis 38:1264-1270 (Pubitemid 34193112)
64. Webb NJ (2000) Immunization against varicella in end stage and pre-end stage renal failure. Arch Dis Child 82:141-143 (Pubitemid 30305709)
65. Jha V, Kohli HS, Sud K, Gupta KL, Minz M, Joshi K, Sakhuja V (1999) Laryngeal tuberculosis in renal transplant recipients. Transplantation 68:153-155 (Pubitemid 29352847)
66. Prelog M, Zimmerhackl LB (2010) Varicella vaccination in pediatric kidney and liver transplantation. Pediatr Transplant 14:41-47
67. Yazaki H, Goto N, Uchida K, Kobayashi T, Gatanaga H, Oka S (2009) Outbreak of Pneumocystis jiroveci pneumonia in renal transplant recipients: P. jiroveci is contagious to the susceptible host. Transplantation 88:380-385
68. EBPG Expert Group on Renal Transplantation (2002) European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV. 7.1 Late infections. Pneumocystis carinii pneumonia. Nephrol Dial Transplant 17 [Suppl 4]:36
69. Rabodonirina M, Vanhems P, Couray-Targe S, Gillibert RP, Ganne C, Nizard N, Colin C, Fabry J, Touraine JL, van Melle G, Nahimana A, Francioli P, Hauser PM (2004) Molecular evidence of interhuman transmission of Pneumocystis pneumonia among renal transplant recipients hospitalised with HIV-infected patients. Emerg Infect Dis 10:1766
70. Hocker B, Wendt C, Nahimana A, Tönshoff B, Hauser PM (2005) Molecular evidence of Pneumocystis transmission in pediatric transplant unit. Emerg Infect Dis 11:330
71. De Boer MG, Bruijnesteijn van Coppenraet LE, Gaasbeek A, Berger SP, Gelinck LB, van Houwelingen HC, van den Broek P, Kuijper EJ, Kroon FP, Vandenbroucke JP (2007) An outbreak of Pneumocystis jiroveci pneumonia with 1 predominant genotype among renal transplant recipients: interhuman transmission or a common environmental source? Clin Infect Dis 44:1143
72. Schmoldt S, Schuhegger R, Wendler T, Huber I, Söllner H, Hogardt M, Arbogast H, Heesemann J, Bader L, Sing A (2008) Molecular evidence of nosocomial Pneumocystis jirovecii transmission among 16 patients after kidney transplantation. J Clin Microbiol 46:966
73. Fontana I, Ginevri F, Arcuri V, Basile G, Nocera A, Beatini M, Bonato L, Barocci S, Bertocchi M, Manolitsi O, Valente R, Draghi P, Gusmano R, Valente U (1999) Vesico-ureteral reflux in pediatric kidney transplants: clinical relevance to graft and patient outcome. Pediatr Transplant 3:206-209 (Pubitemid 29399940)
74. Tolkoff-Rubin NE, Cosimi AB, Russell PS, Rubin RH (1982) A controlled study of trimethoprim-sulfamethoxazole prophylaxis of urinary tract infection in renal transplant recipients. Rev Infect Dis 4:614-618
75. Fox BC, Sollinger HW, Belzer FO,Maki DG (1990) A prospective, randomized, double-blind study of trimethoprim-sulfamethoxazole for prophylaxis of infection in renal transplantation: clinical efficacy, absorption of trimethoprim-sulfamethoxazole, effects on the microflora, and the cost-benefit of prophylaxis. Am J Med 89:255-274 (Pubitemid 20323251)
76. Harmon WE, McDonald RA, Reyes JD, Bridges ND, Sweet SC, Sommers CM, Guidinger MK (2005) Pediatric transplantation, 1994-2003. Am J Transplant 5:887-903 (Pubitemid 40461262)
77. Baron PW, Ojogho ON, Yorgin P, Sahney S, Cutler D, Ben-Youssef R, Baqai W, Weissman J, Franco E, Zuppan C, Concepcion W (2008) Comparison of outcomes with low dose anti-thymocyte globulin, basiliximab or no induction therapy in pediatric kidney transplant recipients: a retrospective study. Pediatr Transplant 12:32-39
78. Flaman F, Zieroth S, RaoV RH, Delgado DH (2006) Basiliximab versus rabbit anti-thymocyte globulin for induction therapy in patients after heart transplantation. J Heart LungTransplant 25:1358-1362 (Pubitemid 44692505)
79. Puliyandaa DP, Stableinb DM, Dharnidharkac VR (2007) Younger age and antibody induction increase the risk for infection in pediatric renal transplantation: a NAPRTCS Report. Am J Transplant 7:662-666
80. Ettenger RB (1999) Antibody therapy as an induction regimen in pediatric renal transplantation. Transplant Proc 31:2677-2678 (Pubitemid 29434098)
81. Mourad G, Rostaing L, Legendre C, Garrigue V, Thervet E, Durand D (2004) Sequential protocols using basiliximab versus antithymocyte globulins in renal-transplant patients receiving mycophenolate mofetil and steroids. Transplantation 78:584-590 (Pubitemid 39097106)
82. Lebranchu Y, Bridoux F, Buchler M, Le Meur Y, Etienne I, Toupance O, Hurault de Ligny B, Touchard G, Moulin B, Le Pogamp P, Reigneau O, Guignard M, Rifle G (2002) Immunoprophylaxis with basiliximab compared with antithymocyte globulin in renal transplant patients receiving MMF containing triple therapy. Am J Transplant 2:48-56
83. Clark G, Walsh G, Deshpande P, Koffman G (2002) Improved efficacy of basiliximab over antilymphocyte globulin induction therapy in paediatric renal transplantation. Nephrol Dial Transplant 17:1304-1309 (Pubitemid 34812078)
84. Halloran PF (2004) Immunosuppressive drugs for kidney transplantation. N Engl J Med 351(26):2715-2729 (Pubitemid 39665325)
85. Fortun J, Martin-Davila P, Pascual J, Cervera C, Moreno A, Gavalda J, Aguado JM, Pereira P, Gurguí M, Carratala J, Fogueda M, Montejo M, Blasco F, Bou G, Torre-Cisneros J, RESITRA Transplant Network (2010) Immunosuppressive therapy and infection after kidney transplantation. Transpl Infect Dis. doi:10.1111/j.1399-3062.2010.00526.x
86. Knight RJ, Villa M, Laskey R, Benavides C, Schoenberg L, Welsh M, Kerman RH, Podder H, Van Buren CT, Katz SM, Kahan BD (2007) Risk factors for impaired wound healing in sirolimus-treated renal transplant recipients. Clin Transplant 21:460-465 (Pubitemid 47161821)
87. Grim SA, Slover CM, Sankary H, Oberholzer J, Benedetti E, Clark NM (2006) Risk factors for wound healing complications in sirolimus-treated renal transplant recipients. Transplant Proc 38:3520-3523 (Pubitemid 44920245)
88. Valente JF, Hricik D, Weigel K, Seaman D, Knauss T, Siegel CT, Bodziak K, Schulak JA (2003) Comparison of sirolimus vs. mycophenolate mofetil on surgical complications and wound healing in adult kidney transplantation. Am J Transplant 3:1128-1134 (Pubitemid 37064553)
89. McWilliams TJ, Levvey BJ, Russell PA, Milne DG, Snell GI (2003) Interstitial pneumonitis associated with sirolimus: a dilemma for lung transplantation. J Heart LungTransplant 22:210-213 (Pubitemid 36173681)
90. Howard L, Gopalan D, Griffiths M, Mahadeva R (2006) Sirolimus-induced pulmonary hypersensitivity associated with a CD4 T-cell infiltrate. Chest 129:1718-1721 (Pubitemid 43895005)
91. Pham PT, Pham PC, Danovitch GM, Ross DJ, Gritsch HA, Kendrick EA, Singer J, Shah T, Wilkinson AH (2004) Sirolimusassociated pulmonary toxicity. Transplantation 77:1215-1220
92. Marty FM, Bryar J, Browne SK, Schwarzberg T, Ho VT, Bassett IV, Koreth J, Alyea EP, Soiffer RJ, Cutler CS, Antin JH, Baden LR (2007) Sirolimus-based graft-versus host disease prophylaxis protects against cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation: a cohort analysis. Blood 110:490-500 (Pubitemid 47105386)
93. Ozaki KS, Camara NO, Nogueira E, Pereira MG, Granato C, Melaragno C, Camargo LF, Pacheco-Silva A (2007) The use of sirolimus in ganciclovir-resistant cytomegalovirus infections in renal transplant recipients. Clin Transplant 21:675-680 (Pubitemid 47399434)
94. Trotter JF, Wallack A, Steinberg T (2003) Low incidence of cytomegalovirus disease in liver transplant recipients receiving sirolimus primary immunosuppression with 3-day corticosteroid taper. Transpl Infect Dis 5:174-180 (Pubitemid 41709866)
95. Eisen HJ, Tuzcu EM, Dorent R, Kobashigawa J, Mancini D, Valantine-von Kaeppler HA, Starling RC, Sørensen K, Hummel M, Lind JM, Abeywickrama KH, Bernhardt P, RAD B253 Study Group (2003) Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients. N Engl J Med 349:847-858 (Pubitemid 37025404)
96. Vitko S, Margreiter R, Weimar W, Dantal J, Viljoen HG, Li Y, Jappe A, Cretin N, RAD B201 Study Group (2004) Everolimus (Certican) 12-month safety and efficacy versus mycophenolate mofetil in de novo renal transplant recipients. Transplantation 78:1532-1540 (Pubitemid 39552941)
97. Mathew TH (1998) A blinded, long-term, randomized multicenter study of mycophenolate mofetil in cadaveric renal transplantation: results at three years. Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group. Transplantation 65:1450-1454 (Pubitemid 28285243)
98. Fisher RA, Stone JJ, Wolfe LG, Rodgers CM, Anderson ML, Sterling RK, Shiffman ML, Luketic VA, Contos MJ, Mills AS, Ferreira-Gonzalez A, Posner MP (2004) Four-year follow-up of a prospective randomized trial of mycophenolate mofetil with cyclosporine microemulsion or tacrolimus following liver transplantation. Clin Transplant 18:463-472 (Pubitemid 39077084)
99. Kobashigawa J, Miller L, Renlund D, Mentzer R, Alderman E, Bourge R, Costanzo M, Eisen H, Dureau G, Ratkovec R, Hummel M, Ipe D, Johnson J, Keogh A, Mamelok R, Mancini D, Smart F, Valantine H (1998) A randomized active-controlled trial of mycophenolate mofetil in heart transplant recipients. Mycophenolate Mofetil Investigators. Transplantation 66:507-515 (Pubitemid 28415379)
100. Webster AC, Caring for Australians with Renal Impairment (CARI) (2007) The CARI guidelines. Calcineurin inhibitors in renal transplantation: the addition of anti-CD25 antibody induction to standard immunosuppressive therapy for kidney transplant recipients. Nephrology 12:S75-S84
101. Jose M, Caring for Australians with Renal Impairment (CARI) (2007) The CARI guidelines. Calcineurin inhibitors in renal transplantation: adverse effects. Nephrology 12:S66-S74
102. Gea-Banacloche JC, Opal SM, Jorgensen J, Carcillo JA, Sepkowitz KA, Cordonnier C (2004) Sepsis associated with immunosuppressive medications: an evidence-based review. Crit Care Med 32[11 Suppl]:S578-S590 (Pubitemid 39489032)
103. Kamara N, Miliotoa O, Puissant-Lubranoc B, Espositoa L, Pierrea MC, Ould Mohameda Lavayssierea A, Cointaulta O, Ribesa D, Cardeaua I, Nogiera MB, Duranda D, Abbalc M, Blancherc A, Rostainga L (2010) Incidence and predictive factors for infectious disease after rituximab therapy in kidney-transplant patients. Am J Transplant 10:89-98